STRN3 | Striatin, calmodulin binding protein 3 | Plasma proteins
| | | | | Expressed in all |
NUBPL | Nucleotide binding protein-like | Disease related genes Predicted secreted proteins
| | | | | Expressed in all |
AKAP6 | A kinase (PRKA) anchor protein 6 | Predicted membrane proteins
| | | | | Tissue enhanced |
EAPP | E2F-associated phosphoprotein | | | | | | Expressed in all |
SNX6 | Sorting nexin 6 | Plasma proteins
| | | | | Expressed in all |
CFL2 | Cofilin 2 (muscle) | Disease related genes Plasma proteins
| | | | | Expressed in all |
BAZ1A | Bromodomain adjacent to zinc finger domain, 1A | | | | | | Expressed in all |
SRP54 | Signal recognition particle 54kDa | Plasma proteins Transporters
| | | | | Expressed in all |
FAM177A1 | Family with sequence similarity 177, member A1 | Predicted secreted proteins
| | | | | Expressed in all |
PSMA6 | Proteasome (prosome, macropain) subunit, alpha type, 6 | Enzymes Plasma proteins
| | | | | Expressed in all |
NFKBIA | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
RALGAPA1 | Ral GTPase activating protein, alpha subunit 1 (catalytic) | Predicted membrane proteins
| | | | | Expressed in all |
BRMS1L | Breast cancer metastasis-suppressor 1-like | | | | | | Expressed in all |
MBIP | MAP3K12 binding inhibitory protein 1 | | | | | | Expressed in all |
NKX2-1 | NK2 homeobox 1 | Cancer-related genes Disease related genes Transcription factors
| | | | | Group enriched |
MIPOL1 | Mirror-image polydactyly 1 | Disease related genes Plasma proteins
| | | | | Mixed |
FOXA1 | Forkhead box A1 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
SSTR1 | Somatostatin receptor 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC14A | C-type lectin domain family 14, member A | Predicted membrane proteins
| | | | | Tissue enhanced |
GEMIN2 | Gem (nuclear organelle) associated protein 2 | | | | | | Expressed in all |
PNN | Pinin, desmosome associated protein | Transporters
| | | | | Expressed in all |
MIA2 | Melanoma inhibitory activity 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
RP11-407N17.3 | CTAGE family member 5 isoform 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
CTAGE5 | CTAGE family, member 5 | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
FKBP3 | FK506 binding protein 3, 25kDa | Enzymes Plasma proteins
| | | | | Expressed in all |
FANCM | Fanconi anemia, complementation group M | Disease related genes Enzymes Potential drug targets
| | | | | Mixed |
MDGA2 | MAM domain containing glycosylphosphatidylinositol anchor 2 | Predicted membrane proteins
| | | | | Group enriched |
RPS29 | Ribosomal protein S29 | Ribosomal proteins
| | | | | Expressed in all |
MGAT2 | Mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Mixed |
DNAAF2 | Dynein, axonemal, assembly factor 2 | Disease related genes
| | | | | Expressed in all |
POLE2 | Polymerase (DNA directed), epsilon 2, accessory subunit | Enzymes FDA approved drug targets
| | | | | Mixed |
KLHDC1 | Kelch domain containing 1 | | | | | | Expressed in all |
SOS2 | Son of sevenless homolog 2 (Drosophila) | Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
MAP4K5 | Mitogen-activated protein kinase kinase kinase kinase 5 | Enzymes
| | | | | Expressed in all |
SAV1 | Salvador homolog 1 (Drosophila) | | | | | | Expressed in all |
NIN | Ninein (GSK3B interacting protein) | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
PYGL | Phosphorylase, glycogen, liver | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
TMX1 | Thioredoxin-related transmembrane protein 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
C14orf166 | Chromosome 14 open reading frame 166 | | | | | | Expressed in all |
ERO1L | ERO1-like (S. cerevisiae) | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PSMC6 | Proteasome (prosome, macropain) 26S subunit, ATPase, 6 | | | | | | Expressed in all |
GNPNAT1 | Glucosamine-phosphate N-acetyltransferase 1 | Enzymes
| | | | | Expressed in all |
FERMT2 | Fermitin family member 2 | Cytoskeleton related proteins
| | | | | Mixed |
CDKN3 | Cyclin-dependent kinase inhibitor 3 | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
CNIH1 | Cornichon family AMPA receptor auxiliary protein 1 | Predicted membrane proteins
| | | | | Expressed in all |
CGRRF1 | Cell growth regulator with ring finger domain 1 | Predicted membrane proteins
| | | | | Expressed in all |
GCH1 | GTP cyclohydrolase 1 | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
WDHD1 | WD repeat and HMG-box DNA binding protein 1 | Predicted membrane proteins
| | | | | Mixed |
LGALS3 | Lectin, galactoside-binding, soluble, 3 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
DLGAP5 | Discs, large (Drosophila) homolog-associated protein 5 | Plasma proteins
| | | | | Mixed |